查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403470

2030 年精准诊断市场预测：按类型、应用程式、最终用户和地区分類的全球分析

Precision Diagnostics Market Forecasts to 2030 - Global Analysis By Type (Direct to Consumer Tests, Esoteric Tests, Genetic Tests and Other Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球精准诊断市场规模将达793亿美元，预计2030年将达到2,057亿美元，预测期内复合年增长率为14.6%。

改进诊断技术以实现高精度和客製化医疗测试的市场被称为精准诊断市场。精准诊断涉及使用蛋白质体学、基因组学和分子诊断等先进技术对患者样本进行分子分析。该技术可以精确识别与特定疾病相关的基因突变、生物标记和其他分子指标。

根据世界卫生组织 (WHO) 的数据，2021 年 5 月，全球有 163,312,429 人受到 COVID-19 的影响。

提高医疗保健意识

患者和医疗保健专业人员越来越意识到准确的诊断可以对治疗结果产生改变游戏规则的影响。越来越多的人意识到其好处，包括早期发现疾病、客製化治疗方法和更好的患者治疗效果的潜力。此外，越来越多的复杂患者正在寻求尖端的诊断工具，以在分子层面上深入了解他们的健康状况。

初始投资高

实施先进技术需要对专业机械、基础设施和熟练员工进行大量前期投资。例子包括次世代定序和分子分析。这些高昂的初期成本为医疗机构和诊断实验室带来了财务挑战，并可能限制患者获得某些诊断服务。然而，财务负担更大，因为它不仅仅是购买技术，还包括针对医疗专业人员的全面培训课程。

慢性病流行

癌症、心血管疾病和神经系统疾病等疾病的全球负担日益增加，对准确、及时的诊断工具的需求日益增加。透过精确诊断，包括尖端分子和个体化医疗。此外，由于这些疾病通常需要专门治疗，准确而彻底的诊断对于成功介入和改善患者预后至关重要。

资料隐私和安全问题

精确诊断需要收集和分析高度敏感的患者资讯，包括遗传和分子资料，因此确保稳健的资料保护措施极为重要。患者和医疗保健提供者担心其个人健康资讯可能被滥用、资料外洩和诈欺的存取。然而，解决这些问题需要严格遵守 GDPR 和 HIPAA 等资料保护法，并且需要在网路安全基础设施上投入大量资金。

COVID-19 的影响：

这次疫情凸显了快速准确诊断的重要性，但非紧急诊断程序的延迟以及将资源转移到 COVID-19 检测上导致了混乱。该行业对分子诊断（尤其是基于 PCR 的检测）的需求激增，但供应链中断和医院基础设施负担过重困扰着该行业。传统的诊断环境也受到了远端医疗和远距离诊断重点转移的影响。

预计预测期内基因检测领域规模最大

随着精准医疗的普及，基因检测领域拥有最大的市场占有率。对分子谱分析和次世代定序等基因检测的需求正在迅速增加。这些测试可以充分识别个体的遗传组成，从而检测特定的遗传差异、对疾病的易感性以及可能的治疗反应。此外，遗传疾病发生率的增加和个体化医疗保健意识的增强也推动了基因检测在疾病诊断、风险评估和治疗计划中的应用。

预计肿瘤学在预测期内将经历最高的复合年增长率。

随着分子测试、液体活检和基因组分析使识别与各种癌症类型相关的特定遗传变化和生物标记成为可能，肿瘤学领域正在迅速扩展。这种精确度使肿瘤学家能够根据每位患者的肿瘤特异性基因谱量身定制治疗计划，从而优化治疗结果。全球癌症盛行率的不断增加以及对其分子基础的了解不断加深，增加了对肿瘤学准确诊断技术的需求。

比最大的地区

由于癌症和心血管疾病等慢性病盛行率的上升增加了对先进和准确诊断工具的需求，预计亚太地区将在预测期内占据最大的市场份额。该地区的中产阶级人口不断增长，医疗保健专业知识不断提高，特别注重预防性护理。此外，精准诊断的理念是提供量身定制的、有针对性的干预措施，以改善患者的治疗结果，这也符合医疗保健领域的这项运动。

复合年增长率最高的地区：

由于科技的快速进步和医疗保健服务的不断扩大，亚太地区正在经历盈利成长。中国、日本和印度等国家在研发、基础设施和医疗保健方面投入巨资，为引进尖端诊断技术提供了有利的环境。亚太地区持续优先开拓医疗基础设施、投资研发和创新、经历向精准医疗的范式转变，使其成为支撑全球精准诊断市场成长和扩张的主要力量。会的。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球精密诊断市场：依类型

  • 直接面向消费者的测试
  • 困难的考验
  • 基因检测
  • 其他类型

第六章全球精密诊断市场：依应用分类

  • 心血管
  • 免疫学
  • 肿瘤学
  • 呼吸系统疾病
  • 其他用途

第七章全球精密诊断市场：依最终使用者分类

  • 临床实验室
  • 居家护理
  • 医院
  • 其他最终用户

第八章全球精准诊断市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott
  • Bayer AG
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • Novartis AG
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Sanofi
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH
Product Code: SMRC24695

According to Stratistics MRC, the Global Precision Diagnostics Market is accounted for $79.3 billion in 2023 and is expected to reach $205.7 billion by 2030 growing at a CAGR of 14.6% during the forecast period. The market for improved diagnostic technologies that enable very precise and customized medical testing is known as the "precision diagnostics market." Precision diagnostics entails the molecular analysis of patient samples using advanced methods, including proteomics, genomics, and molecular diagnostics. With this method, genetic variants, biomarkers, and other molecular indicators linked to certain diseases can be precisely identified.

According to the World Health Organization (WHO), in May 2021, 163,312,429 people worldwide were affected by COVID-19.

Market Dynamics:

Driver:

Increasing healthcare awareness

Patients and healthcare professionals' awareness of the revolutionary effect accurate diagnosis can have on treatment results is growing. An increasing number of people are becoming aware of the benefits of early disease detection, customized treatment regimens, and the possibility of better patient outcomes. Additionally, more and more sophisticated patients are asking for access to state-of-the-art diagnostic tools that can offer an in-depth understanding of their molecular health.

Restraint:

High upfront costs

Advanced technology adoption requires large upfront investments in specialized machinery, infrastructure, and skilled employees. Some instances of these are next-generation sequencing and molecular profiling. These higher initial costs might pose an economic challenge for medical facilities, and diagnostic labs and potentially restrict patient access to specific precision diagnostic services. However, the financial burden is further increased by the fact that the expenses extend beyond the purchase of technology and involve thorough training courses for medical professionals.

Opportunity:

Growing prevalence of chronic diseases

Accurate and timely diagnostic tools are becoming more and more necessary due to the rising worldwide burden of diseases like cancer, cardiovascular diseases, and neurological disorders. The identification of certain genetic mutations, biomarkers, and molecular signatures associated with a range of chronic conditions is made possible by precision diagnostics, which includes cutting-edge molecular technology and customized medicine techniques. Additionally, accurate and thorough diagnoses are essential for successful intervention and better patient outcomes since these illnesses often require specialized therapies.

Threat:

Data privacy and security concerns

Ensuring strong data protection measures is crucial because precision diagnostics requires the collection and analysis of extremely sensitive patient information, including genetic and molecular data. Patients and healthcare providers are concerned about the possibility of misuse, data breaches, and unauthorized access to personal health information. However, strict adherence to data protection laws, such as GDPR and HIPAA, is necessary to address these issues, necessitating substantial expenditures in cybersecurity infrastructure.

COVID-19 Impact:

While the pandemic emphasized the significance of rapid and accurate diagnosis, delays in non-urgent diagnostic procedures and the redirection of resources toward COVID-19 testing caused disruptions. Demand for molecular diagnostics, especially PCR-based tests, surged in the industry, but supply chain disruptions and overloaded hospital infrastructures posed problems. Traditional diagnostic settings were also impacted by a shift in emphasis toward telemedicine and remote diagnostics.

The genetic tests segment is expected to be the largest during the forecast period

With the growing popularity of precision medicine, the genetic testing sector held the largest market share. Demand for genetic tests, such as molecular profiling and next-generation sequencing, is rapidly rising. An individual's genetic composition can be fully recognized by these tests, which can detect certain genetic differences, illness susceptibility, and possible treatment reactions. Additionally, the use of genetic tests for illness diagnosis, risk assessment, and treatment planning is being driven by the rising frequency of genetic illnesses and the increasing awareness of individualized healthcare.

The oncology segment is expected to have the highest CAGR during the forecast period

Because molecular testing, liquid biopsies, and genomic profiling have made it possible to identify particular genetic changes and biomarkers linked to various cancer types, the oncology sector is expanding rapidly. With this level of accuracy, oncologists can optimize therapeutic outcomes by customizing treatment plans based on each patient's tumor's unique genetic profile. Accurate diagnostic techniques for oncology are in greater demand due to the rising global prevalence of cancer and our growing understanding of its molecular basis.

Region with largest share:

Because the demand for sophisticated and accurate diagnostic tools has increased due to the rising prevalence of chronic diseases, including cancer and cardiovascular disorders, the Asia-Pacific region is anticipated to hold the largest share of the market over the forecasted period. In addition, the area is experiencing a rise in the middle-class population and healthcare expertise, with a particular emphasis on preventive healthcare practices. Moreover, the precision diagnostic tenets of tailored and targeted interventions for better patient outcomes are in accordance with this movement in healthcare perspectives.

Region with highest CAGR:

The Asia-Pacific region is growing profitably as a result of the rapid advancement in technology and the growing availability of healthcare services. Nations like China, Japan, and India have invested large investments in R&D, infrastructure, and healthcare, providing a climate that is favorable to the adoption of cutting-edge diagnostic technology. The Asia Pacific region will definitely be a major force behind the growth and expansion of the precision diagnostics market on a global scale as it continues to prioritize the development of healthcare infrastructure, invest in research and innovation, and experience a paradigm shift towards precision medicine.

Key players in the market:

Some of the key players in Precision Diagnostics market include Abbott, Bayer AG, Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Novartis AG, QIAGEN, Quest Diagnostics Incorporated, Sanofi, Siemens Healthineers AG and Swiss Precision Diagnostics GmbH.

Key Developments:

In October 2023, Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.

In September 2023, Abbott signs definitive agreement to acquire Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. As part of the acquisition, Abbott will use Bigfoot Unity with its FreeStyle Libre technology, which uses a customer smartphone app connected to a cloud-based online portal.

In May 2023, Bayer has secured a long-term structured renewable energy credit purchase agreement with Cat Creek Energy that will generate 1.4 terawatt-hours of clean electricity annually, equivalent to the energy consumption of 150,000 households.

Types Covered:

  • Direct to Consumer Tests
  • Esoteric Tests
  • Genetic Tests
  • Other Types

Applications Covered:

  • Cardiovascular
  • Immunology
  • Oncology
  • Respiratory Diseases
  • Other Applications

End Users Covered:

  • Clinical Laboratories
  • Homecare
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Precision Diagnostics Market, By Type

  • 5.1 Introduction
  • 5.2 Direct to Consumer Tests
  • 5.3 Esoteric Tests
  • 5.4 Genetic Tests
  • 5.5 Other Types

6 Global Precision Diagnostics Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular
  • 6.3 Immunology
  • 6.4 Oncology
  • 6.5 Respiratory Diseases
  • 6.6 Other Applications

7 Global Precision Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Clinical Laboratories
  • 7.3 Homecare
  • 7.4 Hospitals
  • 7.5 Other End Users

8 Global Precision Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott
  • 10.2 Bayer AG
  • 10.3 Koninklijke Philips N.V.
  • 10.4 Lantheus Medical Imaging, Inc.
  • 10.5 Novartis AG
  • 10.6 QIAGEN
  • 10.7 Quest Diagnostics Incorporated
  • 10.8 Sanofi
  • 10.9 Siemens Healthineers AG
  • 10.10 Swiss Precision Diagnostics GmbH

List of Tables

  • Table 1 Global Precision Diagnostics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
  • Table 4 Global Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
  • Table 5 Global Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 6 Global Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 7 Global Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 8 Global Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 9 Global Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 10 Global Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 11 Global Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
  • Table 12 Global Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 13 Global Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 14 Global Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 15 Global Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 16 Global Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 17 Global Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
  • Table 21 North America Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
  • Table 22 North America Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 23 North America Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 24 North America Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 North America Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 26 North America Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 27 North America Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 28 North America Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
  • Table 29 North America Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 30 North America Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 North America Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 32 North America Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 33 North America Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 34 North America Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
  • Table 38 Europe Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
  • Table 39 Europe Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 40 Europe Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 41 Europe Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 42 Europe Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 43 Europe Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 44 Europe Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 45 Europe Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
  • Table 46 Europe Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 47 Europe Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 48 Europe Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 49 Europe Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 50 Europe Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 51 Europe Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
  • Table 55 Asia Pacific Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
  • Table 56 Asia Pacific Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 57 Asia Pacific Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 58 Asia Pacific Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 59 Asia Pacific Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 60 Asia Pacific Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 61 Asia Pacific Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 62 Asia Pacific Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
  • Table 63 Asia Pacific Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 64 Asia Pacific Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 65 Asia Pacific Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 66 Asia Pacific Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 67 Asia Pacific Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 68 Asia Pacific Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
  • Table 72 South America Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
  • Table 73 South America Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 74 South America Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 75 South America Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 South America Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 77 South America Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 78 South America Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 79 South America Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
  • Table 80 South America Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 81 South America Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 82 South America Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 83 South America Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 84 South America Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 85 South America Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
  • Table 89 Middle East & Africa Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
  • Table 90 Middle East & Africa Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 91 Middle East & Africa Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 92 Middle East & Africa Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
  • Table 93 Middle East & Africa Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 94 Middle East & Africa Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 95 Middle East & Africa Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 96 Middle East & Africa Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
  • Table 97 Middle East & Africa Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 98 Middle East & Africa Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 99 Middle East & Africa Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 100 Middle East & Africa Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 101 Middle East & Africa Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 102 Middle East & Africa Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)